Rv0129c: fbpCRv0340Rv0341: iniBRv0342: iniARv0343: iniCRv1483: mabARv1484: inhARv1854c: ndhRv1592cRv1772Rv1908c: katG1909c: furARv2242: srm R homologRv2243: fabDRv2245: kasARv2247: accD6Rv2427A: oxyRRv2428: ahpCRv2846c: efpARv3139: fadE24Rv3566c: nhoARv3795: embB

Rv1908c

More about Rv1908c on    TBDB.org

More about Rv1908c on    TubercuList

Return to gene list

Display all mutations or select a bar from the histogram above to examine in greater detail

Display high confidence mutations only

Rv1908c: Codons 220 to 239: 8 mutations (high confidence mutations are highlighted in yellow)
Primary reference Polymorphism Nucleotide position Codon position Amino acid Time period Origin Molecular detection method Gene coverage Resistance pattern MIC Susceptibility testing method R/Total isolates R/S isolates with mutation Additional mutations High confidence support
Cockerill FR JID 1995 CAG/GAG 670 224 Gln/Glu 1995 USA, Japan Sequencing Whole gene - "1; catalase 8 mm" Proportionmethod - 1/0 Pro2Ser, Ser17Asn, Met126Ile, Gly169Ala, Ala264Val, Ala281Val, Try337Cys, Arg463Leu -
Cockerill FR JID 1995 CAG/GAG 670 224 Gln/Glu 1995 USA Sequencing Whole gene H <0.12-1ug/ml Proportion method - 39815 Ala424Glu, Pro429Ser -
Ghiladi RA J Am Chem Soc 2005 TAC/TTC 686 229 Tyr/Phe - - - - - - - - - - -
Chan RCY JAC 2007 GTG/GCG 689 230 Val/Ala 1994-2004 Hong Kong PCR-SSCP, Sequencing Whole gene N.S. - Absolute concentration method 250 241 1 -
Baker LV AAC 2005 GGG/GAG 701 234 Gly/Glu 1998 United Kingdom Directed Oligonucleotide array, Sequencing Whole gene H,HS,HE,HSE,MDR ratio>=4 Resistance ratio method 202/378 1/0 - -
Chan RCY JAC 2007 GGG/AGG 700 234 Gly/Arg 1994-2004 Hong Kong PCR-SSCP, Sequencing Whole gene N.S. - Absolute concentration method 250 241 1 -
Chan RCY JAC 2007 AAC/ACC 707 236 Asn/Thr 1994-2004 Hong Kong PCR-SSCP, Sequencing Whole gene N.S. - Absolute concentration method 250 241 1 -
Hai Hua Lin TubercRespirDis 2007 AAC/AAG 714 238 Asn/Lys 2004 South Korea Sequencing Whole gene MDR N.S. N.S 29/29 1/0 katG S140R -

Disclaimer: These are all putative mutations found in drug resistant clinical TB isolates. No a priori decisions have been made as to whether these mutations are causally related to resistance or possible secondary mutations.


© 2010 Andreas Sandgren  |  Supported by the Swedish Research Council  |  Contact Database Curator